Scan to Download Gate App
qrCode
More Download Options
Don't remind me again today

Nasdaq biotechnology company will use 100 million dollars to buy coins.


Propanc Biopharma, listed on NASDAQ, made big news by securing a $100 million financing commitment from family office Hexstone Capital to establish a digital asset portfolio. A biotech company focused on cancer therapy research is going to buy Bitcoin and Ethereum; this move is quite bold.

Hexstone itself plays with BTC, ETH, SOL, and Dogecoin. This time, choosing to provide convertible preferred shares to support crypto allocation for biotech companies indicates that institutional recognition of cryptocurrency as a reserve asset has penetrated into non-core technology sectors. Propanc is using $99 million of its follow-up financing to buy coins, reflecting that high-risk industries are starting to hedge against traditional market volatility and inflation with digital assets.

This is in line with MicroStrategy's strategy of using digital assets to hedge against currency depreciation and optimize the balance sheet. It is expected that in the future, more publicly listed companies from different backgrounds will follow this mixed reserve model. A new round of increase may be coming!
$BTC $ETH
BTC-2.32%
ETH-3.69%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)